Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Changing Landscape of Autoimmune Hemolytic Anemia
Wilma Barcellini, Bruno Fattizzo
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

Autoimmune Hemolytic Anemias
Sigbjørn Berentsen, Wilma Barcellini
New England Journal of Medicine (2021) Vol. 385, Iss. 15, pp. 1407-1419
Closed Access | Times Cited: 140
How I treat warm autoimmune hemolytic anemia
Wilma Barcellini, Bruno Fattizzo
Blood (2021) Vol. 137, Iss. 10, pp. 1283-1294
Open Access | Times Cited: 92
Evans’ Syndrome: From Diagnosis to Treatment
S. Audia, N. Grienay, Morgane Mounier, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 3851-3851
Open Access | Times Cited: 90
Autoimmune hemolytic anemia: current knowledge and perspectives
Sylwia Sulimiera Michalak, Anna Olewicz‐Gawlik, Joanna Rupa‐Matysek, et al.
Immunity & Ageing (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 88
New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy
Wilma Barcellini, Anna Zaninoni, Juri Alessandro Giannotta, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 3859-3859
Open Access | Times Cited: 85
COVID-19 Vaccines and Autoimmune Hematologic Disorders
María Eva Mingot‐Castellano, Nora Butta, Mariana Canaro, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 961-961
Open Access | Times Cited: 40
The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket?
Sigbjørn Berentsen, Bruno Fattizzo, Wilma Barcellini
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
Ceftriaxone-induced immune hemolytic anemia: a case report
Li Wang, Yongxian Jiang, Gen Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Autoimmune Complications in Hematologic Neoplasms
Wilma Barcellini, Juri Alessandro Giannotta, Bruno Fattizzo
Cancers (2021) Vol. 13, Iss. 7, pp. 1532-1532
Open Access | Times Cited: 49
Autoimmune Hemolytic Anemia in the Pediatric Setting
Aikaterini Voulgaridou, Theodosia A. Kalfa
Journal of Clinical Medicine (2021) Vol. 10, Iss. 2, pp. 216-216
Open Access | Times Cited: 48
Autoimmune hemolytic anemia: causes and consequences
Bruno Fattizzo, Wilma Barcellini
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 7, pp. 731-745
Open Access | Times Cited: 35
Molecular pharmacology in complement‐mediated hemolytic disorders
Marta Bortolotti, Wilma Barcellini, Bruno Fattizzo
European Journal Of Haematology (2023) Vol. 111, Iss. 3, pp. 326-336
Open Access | Times Cited: 18
The Immunomodulatory Effect and Clinical Efficacy of Daratumumab in a Patient With Cold Agglutinin Disease
Anna Zaninoni, Juri Alessandro Giannotta, Anna Gallí, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 37
Fostamatinib for warm antibody autoimmune hemolytic anemia: Phase 3, randomized, double‐blind, placebo‐controlled, global study (FORWARD)
David J. Kuter, Caroline I. Piatek, Alexander Röth, et al.
American Journal of Hematology (2023) Vol. 99, Iss. 1, pp. 79-87
Open Access | Times Cited: 15
Bortezomib in autoimmune hemolytic anemia and beyond
Raffaella Pasquale, Juri Alessandro Giannotta, Wilma Barcellini, et al.
Therapeutic Advances in Hematology (2021) Vol. 12
Open Access | Times Cited: 31
Fc receptors gone wrong: A comprehensive review of their roles in autoimmune and inflammatory diseases
Émilie Chalayer, Baptiste Gramont, Franck Zekre, et al.
Autoimmunity Reviews (2021) Vol. 21, Iss. 3, pp. 103016-103016
Open Access | Times Cited: 31
Are Patients With Autoimmune Cytopenias at Higher Risk of COVID-19 Pneumonia? The Experience of a Reference Center in Northern Italy and Review of the Literature
Wilma Barcellini, Juri Alessandro Giannotta, Bruno Fattizzo
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 28
Daratumumab for immune thrombotic thrombocytopenic purpura
J. Berg, Johanna A. Kremer Hovinga, Claudia Pfleger, et al.
Blood Advances (2021) Vol. 6, Iss. 3, pp. 993-997
Open Access | Times Cited: 27
Warm autoimmune hemolytic anemia and the best treatment strategies
David J. Kuter
Hematology (2022) Vol. 2022, Iss. 1, pp. 105-113
Open Access | Times Cited: 21
Strategies to overcome the diagnostic challenges of autoimmune hemolytic anemias
Wilma Barcellini, Bruno Fattizzo
Expert Review of Hematology (2023) Vol. 16, Iss. 7, pp. 515-524
Open Access | Times Cited: 11
Autoimmune Hemolytic Anemia in Children: Clinical Profile and Outcome
Kamran Ali, Bakhtiar Ahmed, Mumtaz Ali Bharo, et al.
Pakistan Journal of Health Sciences (2025), pp. 42-47
Closed Access
Literature review of occurrence, effectiveness, safety, and hospitalization burden of blood transfusion in the management of warm autoimmune hemolytic anemia
Melca Maria Oliveira Barros, Ann Leon, Concetta Crivera, et al.
Hematology (2025) Vol. 30, Iss. 1
Open Access
Immunopathology of Autoimmune Hemolytic Anemia: A Systematic Review of Molecular Mechanisms and Emerging Therapeutic Strategies
Ahmad Maher Al Sayeh, Mohammad Rawashdeh
Journal of Biomedicine and Biochemistry (2025) Vol. 4, Iss. 1, pp. 40-51
Closed Access
Praxisorientierte, rationale Anämieabklärung
Georgia Metzgeroth, Jan Hastka
Deleted Journal (2025)
Closed Access
Development of New Drugs for Autoimmune Hemolytic Anemia
Zhengrui Xiao, Irina Murakhovskaya
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 1035-1035
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top